New tuberculosis vaccine development

Author： Nacy Carol A   Sacksteder Katherine A  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.2, Iss.7, 2002-10, pp. : 741-749

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tuberculosis vaccine development: research, regulatory and clinical strategies

By Brennan Michael J   Morris Sheldon L   Sizemore Christine F  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 9, 2004-09 ,pp. : 1493-1504

Informa Healthcare

Access to resources Recommend Favorite

Toward the development of better vaccine adjuvants

By Ulmer Jeffrey B  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 2, 2002-02 ,pp. : 119-122

Informa Healthcare

Access to resources Recommend Favorite

New adjuvants in evolving vaccine strategies

By Buonaguro Franco M   Tornesello Maria Lina   Buonaguro Luigi  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 7, 2011-07 ,pp. : 827-832

Informa Healthcare

Access to resources Recommend Favorite

Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement

By Ansaldi Filippo   Durando Paolo   Icardi Giancarlo  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 3, 2011-03 ,pp. : 415-427

Informa Healthcare

Access to resources Recommend Favorite

Improved outlook on HIV-1 prevention and vaccine development

By Vasan Sandhya   Michael Nelson L  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 8, 2012-08 ,pp. : 983-994

Informa Healthcare

Access to resources Recommend Favorite